Evidence map›Paper›PMID 35677159›Full record

ArticleFrontiers in oncology2022

Multiple Primary Lung Cancers With ALK Rearrangement: A Case Report and Literature Review.

Zhou Huimin, Wang Xueting, Qi Qi, Feng Lingxin, Yang Xue, Yu Zhuang, Wang Jing

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The value of [BMC medical imaging · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhou HuiminDepartment of Oncology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Wang XuetingDepartment of Oncology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Qi QiDepartment of Oncology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Feng LingxinDepartment of Oncology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Yang XueDepartment of Oncology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Yu ZhuangDepartment of Oncology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Wang JingDepartment of Oncology, the Affiliated Hospital of Qingdao University, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple primary lung cancers (MPLCs) are that patients with lung cancer may present with two primary tumors at the same time (synchronous multiple primary lung cancer, SMPLC) or may develop a second, metachronous primary lung cancer after treatment of the initial lesion. Currently, there are no definitive guidelines for the diagnosis and treatment of multiple primary lung cancers. Herein, we report a case of double primary lung cancers with ALK rearrangement. The patient was treated with chemotherapy, targeted therapy, and radiotherapy. After these treatments, the patient was free of locally recurrent or distant disease at 2 years.

Indexed as

anaplastic lymphoma kinasecombined small cell lung cancermultiple primary malignant neoplasmsnon-small cell lung cancersmall cell lung cancer

Identifiers

PMID35677159
PMCPMC9168597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.